Ginkgo Bioworks Holdings, Inc. DNA
7.46 USD -0.74 (-9.02%)
Regular-session close
7.55 +0.09 +1.21%
After hours · Nov 20, 7:58 PM ET
7.39 Day range 8.28
5.37 52-week range 18.22
- YTD
- -10.23%
- 1 year
- -4.60%
DNA revenue history
Revenue is income from the company’s ordinary business activities.
170,155,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 170,155,000 | -56,888,000 | -25.06% |
| FY 2024 | 2024-12-31 | 227,043,000 | -24,412,000 | -9.71% |
| FY 2023 | 2023-12-31 | 251,455,000 | -226,251,000 | -47.36% |
| FY 2022 | 2022-12-31 | 477,706,000 | 163,869,000 | 52.21% |
| FY 2021 | 2021-12-31 | 313,837,000 | 237,180,000 | 309.40% |
| FY 2020 | 2020-12-31 | 76,657,000 | 22,473,000 | 41.48% |
| FY 2019 | 2019-12-31 | 54,184,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-11T07:00:37.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
